Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on antiendotoxin therapies.

R Stephens1, C Hamilton-Davies

  • 1Centre for Anaesthesia, Middlesex Hospital, London.

Hospital Medicine (London, England : 1998)
|June 20, 2000
PubMed
Summary

Endotoxin plays a role in organ failure and death following critical illness. This review explores current and future therapeutic strategies targeting endotoxin, as effective treatments are still under development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Phylogenomics, trophic ecology, and systematics of the truffle-forming <i>Morchellaceae</i>.

Persoonia·2026
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

The Duke Activity Status Index compared with cardiopulmonary exercise testing in patients undergoing pre-operative assessment for cancer surgery.

Anaesthesia·2023
Same author

European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment.

European heart journal. Quality of care & clinical outcomes·2022
Same author

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022

Area of Science:

  • Critical illness and surgical complications
  • Immunology and inflammation
  • Pharmacology and therapeutics

Background:

  • Endotoxin is a key factor in severe illness, contributing to organ dysfunction and mortality.
  • Current therapeutic options for endotoxin are limited, with many treatments remaining experimental.
  • Understanding endotoxin's role is crucial for developing effective interventions.

Purpose of the Study:

  • To review historical, current, and emerging anti-endotoxin therapies.
  • To provide an overview of the therapeutic landscape for endotoxin-induced complications.
  • To highlight future directions in the development of endotoxin-neutralizing treatments.

Main Methods:

  • Literature review of past, present, and experimental anti-endotoxin therapies.
  • Analysis of the mechanisms of action for various therapeutic approaches.
  • Synthesis of information on the efficacy and limitations of different treatment strategies.

Main Results:

  • A range of anti-endotoxin strategies have been investigated over time.
  • No single commercial therapy is currently established for endotoxin neutralization.
  • Ongoing research focuses on novel approaches to combat endotoxin's effects.

Conclusions:

  • Developing effective anti-endotoxin therapies remains a significant challenge in critical care.
  • Future research should focus on innovative strategies to mitigate endotoxin-mediated organ damage.
  • Targeting endotoxin holds promise for improving outcomes in sepsis and critical illness.

Related Experiment Videos